Ibritumomab Tiuxetan and Ribociclib and Letrozole
Determining the interaction of Ibritumomab Tiuxetan and Ribociclib and Letrozole and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Letrozole and ribociclib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Ribociclib Succinate
- Ibritumomab Tiuxetan-Rid-A-Pain Topical
- Ibritumomab Tiuxetan-Ridactate
- Ibritumomab Tiuxetan-Ridaura
- Ibritumomab Tiuxetan-Rifabutin
- Ibritumomab Tiuxetan-Rifadin
- Ribociclib and Letrozole-Ibrutinib
- Ribociclib and Letrozole-Ibrutinib Capsules
- Ribociclib and Letrozole-Ibrutinib Tablets
- Ribociclib and Letrozole-Ibu
- Ribociclib and Letrozole-IBU Tablets
- Ribociclib and Letrozole-Ibu-2